Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 29, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - May 29, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/28/17 - 5 Top NASDAQ Biotech Stocks: Nutraceutical Gained 48.93 Percent
Last week the Congressional Budget Office revealed the GOP replacement to Obamacare would end up nixing insurance coverage to 26 million american citizens by 2026 in an attempt to reduce $119 billion over the next decade. FDA head Scott Gottlieb announced it would remove the federal hiring freeze to his agency. Nutraceutical CytRx MannKind MEI Phar
5/28/17 - Findings from Bentley University Broaden Understanding of Clinical Trials and Studies (Timelines of translational science: From technology initiation...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Current study results on Clinical Research- Clinical Trials and Studies have been published. We examined timelines of translational science for 138 drugs and biologicals approved by the FDA from 2010-2014 using an analytical model of technology maturation. " Our news journalis
5/28/17 - Researchers Submit Patent Application, "Method of Treating Hyperlipidemia and Atherosclerosis with Mir-30c", for Approval (USPTO 20170121713)
By a News Reporter-Staff News Editor at Heart Disease Weekly From Washington, D.C., NewsRx journalists report that a patent application by the inventors Hussain, Mahmood; Soh, James, filed on January 12, 2017, was made available online on May 11, 2017. The patent's assignee is The Research Foundation for The State University of New York. News edi
5/28/17 - Safety events common for pharmaceuticals and biologics after FDA approval
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Among more than 200 new pharmaceuticals and biologics approved by the U.S. Food and Drug Administration from 2001 through 2010, nearly a third were affected by a postmarket safety event such as issuance of a boxed warning or safety communication, according to a study published
5/27/17 - "Combination Pharmaceutical Composition and Methods of Treating Diseases Or Conditions Associated with Neurodegenerative Diseases" in Patent...
"Combination Pharmaceutical Composition and Methods of Treating Diseases Or Conditions Associated with Neurodegenerative Diseases" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventor Epshtein, Oleg Iliich, filed on January 3, 2017, was made available
5/27/17 - "Method for Preparing Azetidinone Compound and Intermediate of Azetidinone Compound" in Patent Application Approval Process (USPTO 20170121281)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors BAI, Hua; ZHAO, Xuyang; ZHANG, Yuncai; LI, Xufei; ZHANG, Yong; XU, Dezhou; ZHANG, Li; XU, Xiaojie; ZHU, Qifeng; WANG, Xiaoming; YANG, Zhiqing; ZHONG, Zehua; ZHANG, Jian, filed on June 5, 2015, was made available online on May 11, 2017, ac
5/27/17 - Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue [Tehran Times (Iran)]
Should drugs that win FDA approval on an accelerated pathoften without strong evidence of efficacycommand the same high prices as products that undergo the full menu of agency scrutiny? The ideaswhich include lower prices until drugs prove themselves out in confirmatory trialscome amid an unprecedented debate over the price tags on drugs in the U.S
5/27/17 - Attorney General Becerra Announces $33M Nationwide Settlement After Maker of Tylenol, Motrin, Benadryl Produced Adulterated Medicine
California Attorney General Xavier Becerra issued the following news release:. California Attorney General Xavier Becerra announced a $33 million settlement with drug manufacturer Johnson& Johnson after it violated federal regulations between 2009 and 2011 that ensure the quality of certain medicines, including many consumed by children.
5/27/17 - BioCryst gets a big boost from its latest HAE data, but it still faces a dangerous high wire act and giant rivals [Tehran Times (Iran)]
A little more than a year ago, shares of Research Triangle Park, NC- based BioCryst$ BCRX were crushed by a failed Phase II trial for their lead drug for hereditary angioedema, or HAE. Setbacks like that are not new for BioCryst. But the biotech turned to another HAE drug coming up the pipeline.
5/27/17 - Brewery, prescription drug and General Assembly videos pass into law without Hogan's signature [The Frederick News-Post, Md.]
Larry Hogan announced Friday that new laws to address prescription drug price gouging, General Assembly video recording and brewery taproom expansions will take effect without his signature. Others including a multi-state congressional redistricting plan and a paid sick leave measure that passed with veto-proof majorities in the House and Senat
5/27/17 - Cancer scientist tries to help others as he battles his own Stage 4 cancer [The San Diego Union-Tribune]
The lanky, low-key and bearded Point Loma Heights resident has a doctorate in medicinal chemistry and is the co-inventor of Zykadia, an FDA- approved lung cancer drug made by his employer, the massive Switzerland- based pharmaceutical company, Novartis. Four years later, that personal project, with the help of the advocacy group Fight Colorectal Ca
5/27/17 - Celldex`s Immuno-Oncology Pipeline Continues to Impress [Sudan Tribune]
On May 25, we issued an updated research report on Hampton, NJ- based Celldex Therapeutics, Inc. CLDX. So far this year, Celldex`s share price has been trading below the Zacks categorized Medical-Biomed/Genetics industry. Revenues rose 15.3% year over year to $1.5 million in the quarter, beating the Zacks Consensus Estimate of $0.57 million.
5/27/17 - Concert Pharmaceuticals, Lexington, Mass., Assigned Patent for Morphinan Compounds
Concert Pharmaceuticals, Lexington, Massachusetts, has been assigned a patent developed by two co-inventors for morphinan compounds. The co-inventors are Philip B. Graham, Carlisle, Massachusetts, and I. Robert Silverman, Arlington, Massachusetts. Written by Amal Ahmed; edited by Sudarshan Harpal.
5/27/17 - Continuing Support for Prescription Drug Monitoring Program, McCaskill Advocates for County-Level Funding
Following her successful work to ensure county and municipal level prescription drug monitoring programs would be eligible for federal funds, U.S. Senator Claire McCaskill lent her support to the St. Louis County monitoring program grant application, which includes programs from thirteen additional cities and counties across the state and covers ne
5/27/17 - Daewoong Pharmaceutical Pushes into U.S. BTX Market [Syrian Arab News Agency]
With its self-developed botulinum toxin Nabota, Daewoong Pharmaceutical Co. is waking up from its long winter sleep. According to investment banking industry sources on May 25, the stock price of Daewoong Pharmaceutical decreased to as low as 60,000 won last year due to the overall stock price adjustment in the pharmaceutical industry and conflict
5/27/17 - FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson [T-break Tech (Middle East)]
Pfizers biosimilar to blockbuster anemia meds Epogen and Procrit won the support of an FDA expert panel on Thursday, moving another step closer to a potential approval. Indeed, ahead of the panels meeting, FDA reviewers called the Pfizer med highly similar to the reference product, epoetin alfa, sold by Amgen as Epogen and Johnson& Johnson under th
5/27/17 - Global Peptide Therapeutics Market & Clinical Trials Insights, 2022 [Sport360]
-Research and Markets has announced the addition of the "Global Peptide Therapeutics Market& Clinical Trials Insight 2022" report to their offering. Global Peptide Therapeutics Market& Clinical Trials Insight 2022 report gives comprehensive insight into the various clinical and non-clinical issues involved in the development of global peptide drug.
5/27/17 - GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Groundbreaking Study of Epidiolex (cannabidiol) in The New England Journal of Medicine [Sudan Tribune]
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex in...
5/27/17 - Health programs
Through Canonsburg General Hospital's Speaker Series, physicians and other health-care professionals can present free programs on a variety of health-related topics. Medivan service, operated by Canonsburg Ambulance, is available to residents who need transportation to Canonsburg General Hospital for testing or surgery. On-site laboratory services.
5/27/17 - Hogan lets drug price-gouging bill, dozens of others become law without signature [The Baltimore Sun]
Larry Hogan said Friday he will not block a new law giving the Maryland attorney general's office authority to take generic drug makers to court to challenge allegedly excessive price increases. The Republican governor's actions resolve the final questions surrounding the disposition of bills considered by the General Assembly in the 90- day sessio
5/27/17 - McCaskill, Collins Effort to Tackle Cost of Rx Drugs Clears Key Committee Hurdle
Claire McCaskill, D- Mo., issued the following news release:. A bipartisan plan from U.S. Senator Claire McCaskill and Republican Senator Susan Collins of Maine to combat the sudden, aggressive price hikes of generic drugs by promoting competition to help lower costs and improve accessibility cleared a key committee hurdle today and now advances to
5/27/17 - Missouri Senate Must Pass Prescription Drug Monitoring Bill, McCaskill Urges
Following the passage of a prescription drug monitoring program bill by the Missouri House of Representatives, U.S. Senator Claire McCaskill an outspoken advocate for such a program issued the following statement:. I'm heartened to see long-awaited progress on something that'll save lives across Missouri and urge the State Senate to swiftly pas
5/27/17 - OncoQuest to present phase II clinical results of Oregovomab for treatment of ovarian cancer at ASCO annual meet [Syrian Arab News Agency]
OncoQuest, a privately held, biopharmaceutical company focused on the development and commercialization of immunotherapeutic products for the treatment of cancer, has announced the presentation of initial safety and efficacy data from the companys multicenter, randomized phase 2 study in patients with newly diagnosed advanced ovarian cancer at the.
5/27/17 - Opioid maker agrees to $1.6 million settlement in deceptive-advertising case, officials say [The Orange County Register]
May 26 A pharmaceutical company has agreed to a $1.6 million settlement with Southern and Northern California prosecutors over allegations of deceptive advertising of opioid painkillers, Santa Clara officials announced this week. The agreement between Teva Pharmaceuticals, the Santa Clara County Counsel's Office and the Orange County District...
5/27/17 - Researchers Submit Patent Application, "Dengue Virus Specific Multiple HLA Binding T Cell Epitopes for the Use of Universal Vaccine Development", for...
Researchers Submit Patent Application, "Dengue Virus Specific Multiple HLA Binding T Cell Epitopes for the Use of Universal Vaccine Development", for Approval. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week From Washington, D.C., NewsRx journalists report that a patent application by the inventor Philip, Ramila, filed on
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415